API Development

Leading API Development Innovation

At the heart of our operations lies our robust API development framework—a cornerstone of our competitive edge.

We are committed to enhancing processes to gain cost advantages continually. Our dedicated team relentlessly pursues novel synthesis routes and process refinements, ensuring efficiency and innovation. Moreover, we embrace environmentally friendly, green, and safe technologies, underscoring our commitment to sustainability and excellence.

SOLID TUMOR

  • DOCETAXEL TRIHYDRATE
  • ERLOTINIB HYDROCHLORIDE
  • GEFITINIB
  • LAPATANIB DITOSYLATE
  • PEMETREXED DISODIUM HEPTAHYDRATE
  • SORAFENIB TOSYLATE
  • TEMOZOLOMIDE
  • ENZALUTAMIDE
  • AXITINIB
  • SUNITINIB
  • LENVATINIB
  • METHOTREXATE
  • GEMCITABINE
  • HYDROCHLORIDE
  • FLUDARABINE PHOSPHATE
  • HEPTAHYDRATE
  • BICALUTAMIDE
  • IRINOTECAN
  • FULVESTRANT
  • ANASTROZOLE
  • NINTEDANIB
  • PAZOPANIB
  • RUCAPARIB

HEMATOLOGY

  • AZACITIDINE
  • HYDROXYUREA
  • IMATINIB MESYLATE
  • LENALIDOMIDE
  • BORTEZOMIB
  • DASATINIB
  • BENDAMUSTINE HYDROCHLORIDE
  • PLERIXAFOR
  • HYDROXYCARBAMIDE
  • IBRUTINIB

SUPPORTIVE

  • APREPITANT
  • HYDROXYCARBAMIDE
  • ZOLEDRONIC ACID
  • FOS-APREPITANT
  • ELTROMBOPAG OIAMINE

DMF UNDER PREPARATION

  • APREPITANT
  • BENDAMUSTINE HYDROCHLORIDE
  • FOS-APREPITANT
  • LENVATINIB MESYLATE
  • SUNITINIB
  • SORAFENIB TOSYLATE
  • TEMOZOLOMIDE
  • ZOLEDRONIC ACID

API UNDERDEVELOPMENT

  • ERIBULIN IBRUTINIB
  • CERITINIB PALBOCICLIB

Copyright 2024. All right reserved